START DATE OF STUDY: 01/19/17 at 16:34 END DATE OF STUDY: 1/20/17  RECORDING ENVIRONMENT: inpatient EEG TYPE: long term monitoring   HISTORY: a 48 y.o. FEMALE WITH ECMO HYPOTHERMIA PROTCOL.  MEDICATIONS: Current Facility-Administered Medications: potassium chloride IVPB 20 mEq 100 mL vancomycin paste gentamycin 80 mg+vancomycin 1 G+amphotericin 50 mg in NS 1000 mL irrigation sodium chloride irrigation sodium chloride 0.9 % 100 mL with bumetanide 16 mg infusion mupirocin (BACTROBAN) 2 % nasal ointment 1 Application chlorothiazide (DIURIL) 500 mg in dextrose 5 % in water 100 mL IVPB fentaNYL (SUBLIMAZE) 1 mg in sodium chloride 0.9 % 100 mL infusion nesiritide (NATRECOR) 1,500 mcg in dextrose 5 % in water 250 mL infusion heparin 25,000 units (100 units/mL) in 0.45% sodium chloride 250 mL infusion (Premix) dextrose 50% injection 50 mL glucagon (human recombinant) (GLUCAGEN) injection 1 mg insulin regular 100 units in sodium chloride 0.9 % 100 mL infusion EPINEPHrine (ADRENALIN) 2 mg in dextrose 5 % in water 250 mL infusion phenylephrine (NEO-SYNEPHRINE) 80 mg in sodium chloride 0.9 % 250 mL infusion white petrolatum-mineral oil (LACRI-LUBE) ophthalmic ointment 1 Application DOPamine (INTROPIN) 400 mg/250 mL (1,600 mcg/mL) in D5W infusion potassium chloride (KAYCIEL) 20 mEq/15 mL solution 60 mEq propofol (DIPRIVAN) 1000 mg/100 mL IV infusion pantoprazole (PROTONIX) injection 40 mg tiotropium (SPIRIVA) inhalation capsule 18 mcg ferrous sulfate tablet 325 mg acetaminophen (TYLENOL) tablet 650 mg bisacodyl (DULCOLAX) suppository 10 mg polyethylene glycol (GLYCOLAX) packet 17 g senna (SENOKOT) tablet 1 tablet docusate sodium (COLACE) capsule 100 mg polyethylene glycol (GLYCOLAX) packet 17 g ondansetron (PF) (ZOFRAN) injection 4 mg dextrose 50% injection 25 mL aspirin chewable tablet 81 mg albuterol (PROVENTIL HFA;VENTOLIN HFA) inhaler 2 puff sodium chloride 0.9 % injection (flush) 10 mL sodium chloride 0.9 % injection (flush) 10 mL atorvastatin (LIPITOR) tablet 40 mg  Facility-Administered Medications Ordered in Other Encounters: rocuronium (ZEMURON) injection fentaNYL (PF) (SUBLIMAZE) injection EPINEPHrine (ADRENALIN) 2 mg in dextrose 5 % in water 250 mL infusion potassium chloride IVPB insulin regular 100 units in sodium chloride 0.9 % 100 mL infusion insulin regular (HumuLIN R,NovoLIN R) injection  SEDATION: None  TECHNIQUE: A 21 channel electroencephalogram (EEG) was recorded using the International 10-20 system with T1/T2 electrodes and utilized a NicOne system. This was a technically satisfactory record and included a single channel of EKG.  DAY 1 (1/19/2017, 16:34 - 1/20/2017, 07:19)  BACKGROUND: No posterior dominant rhythm was present. Background activity was characterized by diffuse low voltage delta and theta activity with absence of the expected anterior to posterior gradient of frequencies.  Some intermittent diffuse beta is seen.  PAROXSYMAL ACTIVITY (NON-EPILEPTIFORM):  None  EPILEPTIFORM ACTIVITY:  None  EVENTS: No clinical or electrographic events reported or detected  EKG: A single lead captured 90  DAY 1 IMPRESSION & CLINICAL CORRELATION: This is an abnormal long term video EEG due to diffuse background slowing and absent alpha rhythm.  These findings are etiologically nonspecific indicators of moderate diffuse cerebral dysfunction, which is likely in part due to medication effect. No seizures were seen. 
